Millennials eradicate American cheese, JPMorgan dominates bank earnings, and Snap gets a prescription




Snacks Daily show

Summary: Snap’s stock is down 65% since its IPO, so we’ve got a prescription for its 3 diagnoses. Big banks kicked off the 3rd quarter earnings season, so we check out why JPMorgan’s so hot right now. And Millennials aren’t killing American cheese -- we’re eradicating it. And that’s caused cheddar cheese prices to hit record lows.